CEO Total Pay
$8.0M
FY2025 Summary Compensation, near median
The CEO earned $8.0M in FY2025 against median worker pay of $82,784 · Measuring Instruments.
Data updated August 2026
Subscribe to Bio-rad Laboratories, Inc. CEO pay filing updates (RSS)
Answer first
According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $82,784. Industry placement uses the FY2025 SIC-38 peer cohort (# 48 of 86, 45th percentile - below the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Measuring Instruments companies.
Bio-rad Laboratories, Inc. CEO pay vs. every FY2025 complete filing
Total CEO compensation, the full national distribution, this company marked
$8,030,048 Top 48% higher than 52% of 1,423 companies
Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025
CEO total pay ($8.0M) against pay ratio (97:1) for Bio-rad Laboratories, Inc. (marked) and its 4 closest same-industry peers, against the Measuring Instruments industry median on both axes.
Exclusive CEO-to-median-worker bands across 80 complete latest-FY filings in SIC 38. Segments sum to the peer set, not this company's compensation pillar.
A component-level pay breakdown is not reported in Bio-rad Laboratories, Inc.'s structured SEC pay-ratio disclosure. See our methodology →
Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).
| FY | CEO pay | Δ pay | Median worker | Pay ratio | Δ ratio |
|---|---|---|---|---|---|
| 2021 | $8.7M | - | $78,820 | 110:1 | - |
| 2022 | $7.6M | -13% | $79,648 | 95:1 | -15:1 |
| 2023 | $7.5M | -1.5% | $75,317 | 99:1 | +4:1 |
| 2025 | $8.0M | +7.7% | $82,784 | 97:1 | -2:1 |
Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 12208, FY2021–2025. Adjacent-year deltas only.
Bio-rad Laboratories, Inc. disclosed 97:1 CEO-to-worker pay and $8.0M CEO total in FY2025. the CEO earned 97× the median employee ($82,784) in FY2025.
Median employee $82,784 (HIGH-MED); MID · HEAVY stamps put about 97 median-wage years per CEO year.
CEO Total Pay
$8.0M
FY2025 Summary Compensation, near median
Pay Ratio
97:1
Near industry median
Bio-rad Laboratories, Inc. disclosed 97:1 CEO-to-worker pay and $8.0M CEO total in FY2025. The structured pay-ratio disclosure reports the total without line-item components. Measuring Instruments (SIC 38) median ratio is 121:1 across 86 FY2025 filers; Bio-rad Laboratories, Inc.'s $8.0M CEO total is above the $8.0M industry median CEO pay.
Dollar rank #680 and ratio rank #658 split - treat 97:1 as a disclosure, not a fairness score. Open Measuring Instruments peers.
Read our methodology - how this data is sourced, computed, and verified. Bio-rad Laboratories, Inc. disclosed 97:1 CEO-to-worker pay and $8.0M CEO total in FY2025.
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MID · HEAVY · HIGH-MED.
ABS(ceo_total_comp) peer at $8.0M (Δ $2K lighter vs Bio-rad Laboratories, Inc.); MID · HIGH-MED vs this page's MID · HEAVY · HIGH-MED.
ABS(ceo_total_comp) peer at $8.0M (Δ $17K lighter vs Bio-rad Laboratories, Inc.); MODEST · ELITE-MED vs this page's MID · HEAVY · HIGH-MED.
ABS(ceo_total_comp) peer at $8.0M (Δ $27K lighter vs Bio-rad Laboratories, Inc.); MODEST · ELITE-MED vs this page's MID · HEAVY · HIGH-MED.
ABS(ceo_total_comp) peer at $8.0M (Δ $31K lighter vs Bio-rad Laboratories, Inc.); STEEP · LOW-MED vs this page's MID · HEAVY · HIGH-MED.
Illumina, Inc. stamps MID · HEAVY nearest in-SIC by ABS(pay_ratio) to Bio-rad Laboratories, Inc.'s MID filing.
Bio-rad Laboratories, Inc.'s FY2025 package sits #680 by CEO dollars and #658 by ratio under HEAVY · MID.
Bio-rad Laboratories, Inc.'s HEAVY CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.